iridium radioisotopes has been researched along with Invasiveness, Neoplasm in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ares, C; Bieri, S; Dipasquale, G; Khan, H; Miralbell, R; Nouet, P; Ozsoy, O; Pampallona, S; Popowski, Y; Rouzaud, M | 1 |
Katayose, Y; Oda, A; Oikawa, M; Rikiyama, T; Unno, M | 1 |
Bartelink, H; Horenblas, S; Moonen, LM; Nuyten, MJ; van der Voet, JC | 1 |
Bartelink, H; Horenblas, S; Meinhardt, W; Moonen, LM; Pos, F; Schaefer, BS | 1 |
Bland, KI; Graves, TA | 1 |
Filho, WD; Lopes, A; Nakagawa, WT; Novaes, PE; Rossi, BM | 1 |
Guillemin, F; Hoffstetter, S; Hubert, J; Luporsi, E; Marchal, C; Peiffert, D; Pernot, M | 1 |
Brady, L; Cater, J; Gündüz, K; Shields, CL; Shields, JA | 1 |
Ii, N; Kihira, K; Nakatsuka, A; Nomoto, Y; Shoji, K; Takeda, K; Yamakado, K | 1 |
Brennan, MF; Harrison, LB; Hilaris, BS; Shiu, MH | 1 |
3 review(s) available for iridium radioisotopes and Invasiveness, Neoplasm
Article | Year |
---|---|
[Multimodal therapy for unresectable upper and hilar bile duct carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts; Brachytherapy; Cisplatin; Combined Modality Therapy; Diagnostic Imaging; Fluorouracil; Humans; Iridium Radioisotopes; Neoplasm Invasiveness; Neoplasm Staging; Treatment Outcome | 2006 |
Surgery for early and minimally invasive breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Axilla; Biopsy, Needle; Brachytherapy; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Estrogen Antagonists; Female; Fibrocystic Breast Disease; Humans; Hyperplasia; Iridium Radioisotopes; Lymph Node Excision; Lymphatic Metastasis; Mammography; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Precancerous Conditions; Prospective Studies; Quality Assurance, Health Care; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Rate; Tamoxifen; Treatment Outcome | 1996 |
Brachytherapy and function-saving resection of soft tissue sarcoma arising in the limb.
Topics: Amputation, Surgical; Brachytherapy; Combined Modality Therapy; Extremities; Humans; Iridium Radioisotopes; Neoplasm Invasiveness; Postoperative Complications; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 1991 |
7 other study(ies) available for iridium radioisotopes and Invasiveness, Neoplasm
Article | Year |
---|---|
Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study.
Topics: Aged; Androgen Antagonists; Brachytherapy; Disease-Free Survival; Dose Fractionation, Radiation; Feasibility Studies; Humans; Iridium Radioisotopes; Magnetic Resonance Imaging, Interventional; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Pilot Projects; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, Conformal; Urination Disorders | 2009 |
Bladder conservation in selected T1G3 and muscle-invasive T2-T3a bladder carcinoma using combination therapy of surgery and iridium-192 implantation.
Topics: Adult; Aged; Brachytherapy; Carcinoma, Transitional Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Treatment Outcome; Urinary Bladder Neoplasms | 1994 |
[Good results of bladder-preserving treatment in poorly differentiated and invasive bladder carcinoma using interstitial Iridium-192 radiotherapy].
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Carcinoma in Situ; Combined Modality Therapy; Female; Humans; Iridium Radioisotopes; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms | 1996 |
Radiation and chemotherapy instead of surgery for low infiltrative rectal adenocarcinoma: a prospective trial.
Topics: Abdomen; Adenocarcinoma; Adjuvants, Immunologic; Anal Canal; Antidotes; Antimetabolites, Antineoplastic; Brachytherapy; Cesium Radioisotopes; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Iridium Radioisotopes; Leucovorin; Levamisole; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneum; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Survival Rate; Treatment Outcome; Treatment Refusal | 1998 |
[Interstitial brachytherapy in infiltrating cancer of the bladder. The Nancy experience].
Topics: Brachytherapy; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystectomy; Female; Humans; Iridium Radioisotopes; Lymph Node Excision; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Survival Analysis; Urinary Bladder Neoplasms | 1998 |
Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Choroid Neoplasms; Ciliary Body; Cobalt Radioisotopes; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Iridium Radioisotopes; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Radiotherapy Dosage; Retrospective Studies; Ruthenium Radioisotopes; Survival Rate; Treatment Outcome; Uveal Neoplasms | 2000 |
[Advanced hepatocellular carcinoma--feasibility and clinical impact of high-dose-rate brachytherapy on the treatment of lesions growing into biliary trees, portal veins and the vena cava].
Topics: Aged; Biliary Tract; Brachytherapy; Carcinoma, Hepatocellular; Feasibility Studies; Female; Humans; Iridium Radioisotopes; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Portal Vein; Radiotherapy Dosage; Vascular Neoplasms; Venae Cavae | 2001 |